Browsing by Author "Arsenović, Aleksandra (8559402600)"
Now showing 1 - 7 of 7
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Balkan Endemic Nephropathy is still present in the Kolubara Region, Serbia(2005) ;Bukvić, Danica (8559402100) ;Janković, Slavenka (7101906308) ;Arsenović, Aleksandra (8559402600)Djukanović, Ljubica (7006214786)Background. Almost 50 years ago Balkan Endemic Nephropathy (BEN) was first described in Serbia in the village of Sopic where the first field examination was carried out in 1971. Our aim was to find out whether BEN is still present in this region. Methods. Prevalence data on BEN from a field examination run in 1971 were compared with the results of a cross-sectional study conducted in the same village in 1992. In addition, every new case of the disease diagnosed between 1971 and 1992 was recorded retrospectively. The prospective study included 50 members of five BEN families randomly selected from 28 BEN families registered in the village Šopić in 1992. The objective survey and examination of global and tubular kidney function was carried out in all examined persons once yearly in 1998, 1999, and 2000. Results. The overall prevalence of BEN was 6.4% in 1971 and 8.9% in 1992. In the period of 21 years, 161 new BEN patients were detected in 28 families in which the disease had already been recorded. No new family affected by BEN and none of the new patients in 47 families registered previously as nonaffected were discovered. In the prospective study of five BEN families, three new BEN cases were discovered among 50 members, and two patients fulfilled criteria for BEN-suspected ones. Conclusion. Balkan Endemic Nephropathy (BEN) is still present in the village of Šopić, but the clinical course of the disease became more protracted over time. New cases of BEN appeared only in the affected families. Copyright © 2005 Taylor & Francis Inc. - Some of the metrics are blocked by yourconsent settings
Publication Chronic heart failure phenotypes in prevalent patients treated with hemodialysis – a single-center experience(2022) ;Dobričić, Marija (58070913100) ;Pakić, Vesna (58071003700) ;Arsenović, Aleksandra (8559402600) ;Pejović, Vesna (56856805100) ;Kuzmanović, Aleksandra (59597578500) ;Milić, Miodrag (59575041800)Ležaić, Višnja (55904881900)Introduction/Objective Heart failure (HF) is the main cause of morbidity and mortality of hemodialysis (HD) patients. The aim of this cross-sectional single-center study was to examine the following: 1. frequency and characteristics of HF phenotypes in prevalent HD patients, 2. association of HF with traditional and non-traditional risk factors for cardiovascular diseases. Methods We included all 96 maintenance HD patients from Special Hospital for Internal Diseases, Lazarevac, Serbia, and determined the prevalence of HF with preserved ejection fraction (HFpEF) (per the 2016 criteria of the European Society of Cardiology) and HF with reduced and moderately reduced EF – HFrEF + HFmrEF – together in a group HFrEF (EF < 50%) using standardized post-HD transthoracic echocardiography. Clinical, routine laboratory and volume status parameters (by bioimpedance spectroscopy) was assessed. Results Sixty-three out of 96 examined patients (65.6%) had HF, among them 42 had HFpEF (66.7%), and 21 had HFrEF (33.3%). HFrEF was more common in older males, with diabetic nephropathy as underlying kidney disease, with a longer dialysis vintage and in those with a previous history of ischemic heart disease. HFpEF was more common in males, with lower HD quality (kT/V) and higher pre-dialytic systolic blood pressure. In multivariable regression analysis, HFrEF was associated with diabetic nephropathy, hypervolemia (positively) and triglycerides (negatively), while HFpEF was associated negatively with hemoglobin, iron, and triglycerides. Conclusion In order to control patients on maintenance HD with HF, in addition to appropriate drug therapy, it is advice to control of volemia and maintaining triglyceride, hemoglobin, and iron concentration approximately within normal limits. © 2022, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Detection of renal dysfunctions in family members of patients with Balkan endemic nephropathy(2005) ;Arsenović, Aleksandra (8559402600) ;Bukvić, Danica (8559402100) ;Trbojević, Staljinka (55376510700) ;Marić, Ivko (8559402300)Djukanović, Ljubica (55397855900)Background/Aim: Recent studies have questioned whether new cases of Balkan endemic nephropathy (BEN) are occurring. The aim of the present study was to find out whether new members with renal dysfunctions can be identified among family members of BEN patients from the Kolubara region. Methods: The study included 47 family members of 5 BEN patients on hemodialysis (HD) and 17 members of 3 non-BEN patients on HD. Their medical and epidemiological histories were taken, an objective survey made, and all persons were examined for global and tubular kidney function. Results: Seven BEN family members (2 with previously known BEN) had creatinine clearance (Ccr) below the 75th percentile rank according to sex and age. All non-BEN family members had normal Ccr and no evidence of previous renal disorders. Hypertension was found in 20 (43%) BEN and 6 (35%) non-BEN family members. No significant differences in the frequency of renal function disorders (proteinuria, α 1 -microglobulinuria, urine specific gravity. osmolality, functional excretion of sodium, tubular phosphate resorption) or anemia were found between the groups. Renal disorders were detected in 18 BEN family members without previously detected disease, 3 of whom fulfilled criteria for a diagnosis of BEN and another 2 for BEN-suspected persons. Conclusion: New cases of BEN are still arising among the affected families in the Kolubara region. Copyright © 2005 S. Karger AG. - Some of the metrics are blocked by yourconsent settings
Publication Gender-specific differences in hemodialysis patients: a multicenter longitudinal study from Serbia(2022) ;Djukanović, Ljubica (7006214786) ;Ležaić, Višnja (55904881900) ;Dimković, Nada (6603958094) ;Marinković, Jelena (7004611210) ;Aksić Milićević, Biserka (55191338600) ;Arsenijević, Svetlana (57775974700) ;Arsenović, Aleksandra (8559402600) ;Ceković, Biljana (57193213606) ;Ćelić, Dejan (25642365700) ;Djordjević, Verica (57196659548) ;Djurin, Miloš (57776883900) ;Filipović, Nenad (57777334000) ;Gajić, Selena (57221714702) ;Haviža-Lilić, Branimir (6504026199) ;Jandrić, Miloš (57775974800) ;Jovanović, Nasta (56770882300) ;Knežević, Violeta (55751805200) ;Krsmanović, Svetlana (57776205500) ;Marković, Dragana (24426339600) ;Maksić, Djoko (59835421000) ;Maslovarić, Jelena (56239036200) ;Milanović, Snežana (57775974900) ;Mitić, Branka (6603935414) ;Ostojić, Ana (57776884000) ;Petković, Dobrila (57193212043) ;Pilipović, Dragana (56771531100) ;Sokolović, Miodrag (57044590900) ;Stanković, Dragana (57777334100) ;Stojanović, Marina (7004959134) ;Stojšić Vuksanović, Tatjana (57776435400) ;Tirmenštajn, Biserka (57776884100) ;Uzelac, Jadranka (57776435500) ;Vesić, Nataša (57776205600) ;Vojinović, Goran (56771390200)Vukša, Vanja (57776435600)Purpose: The study was undertaken with the aim to determine gender-specific differences in incident hemodialysis (HD) patient and their changes over time. Methods: The retrospective longitudinal closed cohort study involved 441 incident patients starting HD in 2014 and followed for 1–59 (median 43, IQR 40) months. Demographic, clinical data, treatment characteristics, laboratory findings and outcome were abstracted from the patients’ medical records. Results: The relative number of males on HD was about twice that of females throughout the five years investigated. At the beginning of the study, no significant differences were found in the main demographic and clinical characteristics except that diabetes was more often the underlying disease in men than in women. Systolic blood pressure decreased over time significantly more in females than in males. Throughout the study spKt/V was significantly higher in females than in males, but it increased in patients of both genders. There were no gender differences for comorbidities, vascular access and the majority of laboratory findings except for higher serum levels of creatinine and CRP in men than in women. Relatively more females were treated with erythropoiesis stimulating agents and phosphate binders than males. Age and malignancy were selected as significant predictors of mortality for both genders, and, in addition, polycystic kidney disease, serum level of albumin and CRP for men, but spKt/V for women. Conclusion: Some significant gender differences were observed throughout, while others appeared during the study but none of them were due to gender inequalities in the applied treatment. © 2022, The Author(s), under exclusive licence to Springer Nature B.V. - Some of the metrics are blocked by yourconsent settings
Publication Prevalence of Balkan endemic nephropathy has not changed since 1971 in the Kolubara region in Serbia(2007) ;Bukvić, Danica (8559402100) ;Marić, Ivko (8559402300) ;Arsenović, Aleksandra (8559402600) ;Janković, Slavenka (7101906308)Djukanović, Ljubica (7006214786)Background/Aims: Thirty-one years after the first cross-sectional study, the population of Vreoci, a Balkan endemic nephropathy (BEN) village, was reinvestigated in order to determine the current prevalence of BEN and the clinical and laboratory characteristics of BEN family members with detected signs of kidney disease. Methods: A total of 2,009 inhabitants (82% of the adult population) of the village were examined. Danilovic's criteria were used for diagnosis and classification of BEN. Results: The prevalence of BEN (1.70%) was similar to that in 1971 (1.67%). Diagnosis of BEN was established in 19 BEN family members, suspected BEN in 23, proteinuria in 29, while 16 healthy members were examined as controls. Urine protein, alpha1-microglobulin levels and frequency of glucosuria were significantly higher and kidney length significantly smaller in the three patient groups than in healthy persons. Serum urea and creatinine levels were significantly higher, but creatinine clearance was lower in BEN and BEN suspected patients than in the other two groups. Conclusion: The prevalence of BEN remains stable over time in Vreoci village. Manifested disease was found in both BEN and BEN suspected patients. In persons with proteinuria but not enough criteria for BEN, tubular disorders and hypertension were frequently found. Copyright © 2007 S. Karger AG. - Some of the metrics are blocked by yourconsent settings
Publication Successful treatment of chronic hepatitis C in a hemodialysis(2018) ;Milošević, Ivana (58456808200) ;Karić, Uroš (57201195591) ;Pešić-Pavlović, Ivana (36473869000) ;Stevanović, Goran (15059280200) ;Barać, Aleksandra (55550748700) ;Smiljanić, Marijana (57195930591) ;Arsenović, Aleksandra (8559402600) ;Stevanović, Olja (57201195181) ;Đonin-Nenezić, Miljana (57201195027)Brmbolić, Branko (6701712863)We present the first case of successful direct acting antiviral therapy of chronic hepatitis C in a hemodialysis patient in Serbia. The patient infected with genotype 1a has been successfully treated with Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ribavirin. There are only a few real world reports regarding this therapeutic option in hemodialysis patients. © 2018 Milošević et al. - Some of the metrics are blocked by yourconsent settings
Publication Successful treatment of chronic hepatitis C in a hemodialysis(2018) ;Milošević, Ivana (58456808200) ;Karić, Uroš (57201195591) ;Pešić-Pavlović, Ivana (36473869000) ;Stevanović, Goran (15059280200) ;Barać, Aleksandra (55550748700) ;Smiljanić, Marijana (57195930591) ;Arsenović, Aleksandra (8559402600) ;Stevanović, Olja (57201195181) ;Đonin-Nenezić, Miljana (57201195027)Brmbolić, Branko (6701712863)We present the first case of successful direct acting antiviral therapy of chronic hepatitis C in a hemodialysis patient in Serbia. The patient infected with genotype 1a has been successfully treated with Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ribavirin. There are only a few real world reports regarding this therapeutic option in hemodialysis patients. © 2018 Milošević et al.
